In this quarterly report on Form 10-Q, Mesa Laboratories, Inc., a Colorado corporation, together with its subsidiaries is collectively referred to as “we,” “us,” “our,” the “Company” or “Mesa.” We are organized into four divisions across nine physical locations.
Biological, cleaning, and chemical indicators are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries.
Our Instruments Division designs, manufactures, and markets quality control instruments and disposable products utilized in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries.
Our Cold Chain Monitoring Division designs, develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments.
Our Cold Chain Packaging Division provides packaging development consulting services and thermal packaging products such as coolers, boxes, insulation materials, and phase-change products to control temperature during the customer’s transport of their own products.
In August 2018, the SEC issued Release No.
The principal change to our financial reporting will be the inclusion of the annual disclosure requirement of changes in stockholders’ equity in Rule 3-04 of Regulation S-X to interim periods.
We will adopt this new rule beginning with our financial reporting for the quarter ended December 31, 2018.
Effective April 1, 2018, we adopted ASU 2014-09 Revenue from Contracts with Customers (Topic 606) and all related amendments (referred to collectively hereinafter as “ASU 606”) on a modified retrospective basis.Item 2.
Management believes that these forward-looking statements are reasonable as and when made.
Our Instruments Division designs, manufactures, and markets quality control instruments and disposable products utilized in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries.
Our Cold Chain Packaging Division provides packaging development consulting services and thermal packaging products such as coolers, boxes, insulation materials, and phase-change products to control temperature during the customer’s transport of their own products.
Sterilization and disinfection control products and most products in our Cold Chain Packaging Division are disposable and are used on a routine basis, thus product sales are less sensitive to general economic conditions.
Overall revenues increased eight percent, while organic revenues increased three percent, for the three months ended September 30, 2018, resulting from organic increases of nine percent and three percent from the Instruments and SDC Divisions, respectively, partially offset by organic decreases of six percent and 11 percent for the Cold Chain Monitoring and Cold Chain Packaging Divisions, respectively.
Overall revenues increased 10 percent, while organic revenues increased three percent, for the six months ended September 30, 2018, resulting from organic increases of 23 percent, five percent, and two percent from the Cold Chain Packaging, Instruments, and Cold Chain Monitoring Divisions, respectively, partially offset by an organic decrease of one percent for the SDC Division.
Cold Chain Packaging revenues decreased 11 percent and increased 24 percent for the three and six months ended September 30, 2018, respectively, as a result of changes in the order rate of the division’s largest customer.Part II.